Immunoprecise Antibodies Ltd
IPA2.070USD
0.0000.00%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
95.54M시가총액
손실P/E TTM
자세한 내용은 Immunoprecise Antibodies Ltd 회사
ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.
Immunoprecise Antibodies Ltd 정보
종목 코드 IPA
회사 이름Immunoprecise Antibodies Ltd
상장일Jan 30, 1987
CEODr. Jennifer Lynne Bath, Ph.D.
직원 수- -
유형Ordinary Share
회계 연도 종료Jan 30
주소Industrious 823 Congress Ave Suite 300
도시AUSTIN
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호78701
전화16048060626
웹사이트https://www.ipatherapeutics.com/
종목 코드 IPA
상장일Jan 30, 1987
CEODr. Jennifer Lynne Bath, Ph.D.
Immunoprecise Antibodies Ltd의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Jennifer Lynne Bath, Ph.D.
Dr. Jennifer Lynne Bath, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
498.12K
--
Dr. Kamil Isaev
Dr. Kamil Isaev
Independent Director
Independent Director
3.19K
--
Mr. Dirk Witters
Mr. Dirk Witters
Independent Director
Independent Director
1.95K
--
Ms. Kari Graber
Ms. Kari Graber
Vice President - Commercial Services
Vice President - Commercial Services
700.00
--
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Director
Director
--
--
Mr. Joseph Scheffler
Mr. Joseph Scheffler
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Dr. Shuji Sato
Dr. Shuji Sato
Vice President - Innovative Solutions
Vice President - Innovative Solutions
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. Jennifer Lynne Bath, Ph.D.
Dr. Jennifer Lynne Bath, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
498.12K
--
Dr. Kamil Isaev
Dr. Kamil Isaev
Independent Director
Independent Director
3.19K
--
Mr. Dirk Witters
Mr. Dirk Witters
Independent Director
Independent Director
1.95K
--
Ms. Kari Graber
Ms. Kari Graber
Vice President - Commercial Services
Vice President - Commercial Services
700.00
--
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Director
Director
--
--
Mr. Joseph Scheffler
Mr. Joseph Scheffler
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
수익 분석
통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2026Q2
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
사업별USD
이름
수익
비율
Project revenue
4.06M
98.40%
Cryo storage revenue
66.00K
1.60%
Product sales revenue
0.00
0.00%
지역별USD
이름
수익
비율
United States of America
2.40M
58.20%
Europe
900.00K
21.82%
Other
550.00K
13.34%
Australia
226.00K
5.48%
Canada
48.00K
1.16%
사업별
지역별
사업별USD
이름
수익
비율
Project revenue
4.06M
98.40%
Cryo storage revenue
66.00K
1.60%
Product sales revenue
0.00
0.00%
주식 보유 통계
마지막 업데이트: Sat, Feb 7
마지막 업데이트: Sat, Feb 7
주주
주주 유형
주주
주주
비율
Charmquark TWEE
7.83%
Ingalls & Snyder LLC (Asset Management)
5.78%
Susquehanna International Group, LLP
1.07%
Bath (Jennifer Lynne)
1.07%
Renaissance Technologies LLC
0.47%
기타
83.77%
주주
주주
비율
Charmquark TWEE
7.83%
Ingalls & Snyder LLC (Asset Management)
5.78%
Susquehanna International Group, LLP
1.07%
Bath (Jennifer Lynne)
1.07%
Renaissance Technologies LLC
0.47%
기타
83.77%
주주 유형
주주
비율
Corporation
7.83%
Investment Advisor/Hedge Fund
6.31%
Investment Advisor
1.38%
Individual Investor
1.21%
Hedge Fund
0.71%
Research Firm
0.18%
Venture Capital
0.08%
Bank and Trust
0.07%
기타
82.24%
기관 주식 보유
마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
48
4.08M
8.74%
-217.78K
2025Q3
41
3.90M
8.45%
-302.90K
2025Q2
46
8.16M
23.11%
+1.40M
2025Q1
45
6.32M
13.81%
+742.61K
2024Q4
45
4.34M
9.53%
-1.30M
2024Q3
46
5.39M
19.68%
+72.87K
2024Q2
48
5.12M
19.96%
-156.62K
2024Q1
50
5.14M
20.20%
-196.19K
2023Q4
58
5.33M
20.96%
+124.72K
2023Q3
50
4.91M
19.67%
-438.42K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Charmquark TWEE
3.66M
7.83%
--
--
Jul 25, 2025
Ingalls & Snyder LLC (Asset Management)
2.70M
5.78%
-79.67K
-2.87%
Sep 30, 2025
Susquehanna International Group, LLP
501.70K
1.07%
-197.54K
-28.25%
Sep 30, 2025
Bath (Jennifer Lynne)
498.12K
1.07%
--
--
Aug 27, 2025
Renaissance Technologies LLC
220.48K
0.47%
+180.00K
+444.66%
Sep 30, 2025
Marshall Wace LLP
168.65K
0.36%
+168.65K
--
Sep 30, 2025
Two Sigma Investments, LP
108.93K
0.23%
+18.08K
+19.90%
Sep 30, 2025
Allianz Global Investors Asia Pacific Limited
60.00K
0.13%
+60.00K
--
Sep 30, 2025
Morgan Stanley Smith Barney LLC
55.00K
0.12%
+45.00K
+450.00%
Sep 30, 2025
XTX Markets LLC
37.39K
0.08%
-53.99K
-59.08%
Sep 30, 2025
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
